Dik Jan-Willem H, Hendrix Ron, Friedrich Alex W, Luttjeboer Jos, Panday Prashant Nannan, Wilting Kasper R, Lo-Ten-Foe Jerome R, Postma Maarten J, Sinha Bhanu
Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Certe Laboratory for Infectious Diseases, Groningen, the Netherlands.
PLoS One. 2015 May 8;10(5):e0126106. doi: 10.1371/journal.pone.0126106. eCollection 2015.
In order to stimulate appropriate antimicrobial use and thereby lower the chances of resistance development, an Antibiotic Stewardship Team (A-Team) has been implemented at the University Medical Center Groningen, the Netherlands. Focus of the A-Team was a pro-active day 2 case-audit, which was financially evaluated here to calculate the return on investment from a hospital perspective.
Effects were evaluated by comparing audited patients with a historic cohort with the same diagnosis-related groups. Based upon this evaluation a cost-minimization model was created that can be used to predict the financial effects of a day 2 case-audit. Sensitivity analyses were performed to deal with uncertainties. Finally, the model was used to financially evaluate the A-Team.
One whole year including 114 patients was evaluated. Implementation costs were calculated to be €17,732, which represent total costs spent to implement this A-Team. For this specific patient group admitted to a urology ward and consulted on day 2 by the A-Team, the model estimated total savings of €60,306 after one year for this single department, leading to a return on investment of 5.9.
The implemented multi-disciplinary A-Team performing a day 2 case-audit in the hospital had a positive return on investment caused by a reduced length of stay due to a more appropriate antibiotic therapy. Based on the extensive data analysis, a model of this intervention could be constructed. This model could be used by other institutions, using their own data to estimate the effects of a day 2 case-audit in their hospital.
为了促进合理使用抗菌药物,从而降低耐药性产生的几率,荷兰格罗宁根大学医学中心设立了抗生素管理团队(A团队)。A团队的工作重点是在第二天进行主动病例审核,并在此从医院角度对其进行财务评估以计算投资回报率。
通过将接受审核的患者与具有相同诊断相关组的历史队列进行比较来评估效果。基于该评估创建了一个成本最小化模型,可用于预测第二天病例审核的财务影响。进行敏感性分析以应对不确定性。最后,使用该模型对A团队进行财务评估。
评估了包括114名患者的一整年情况。实施成本计算为17,732欧元,这代表实施该A团队的总支出。对于入住泌尿外科病房并在第二天接受A团队会诊的这个特定患者群体,该模型估计该单个科室一年后总节省60,306欧元,投资回报率为5.9。
在医院实施的在第二天进行病例审核的多学科A团队,由于更合理的抗生素治疗导致住院时间缩短,从而产生了正的投资回报率。基于广泛的数据分析,可以构建这种干预措施的模型。其他机构可以使用该模型,利用自己的数据来估计在其医院进行第二天病例审核的效果。